Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Insurance
    • Cigna to increase...

    Cigna to increase stake in Cigna TTK JV to 49 percent

    Written by Ruby Khatun Khatun Published On 20 Aug 2017 3:45 AM  |  Updated On 20 Aug 2017 3:45 AM
    Cigna to increase stake in Cigna TTK JV to 49 percent

    Mumbai: Private health insurer Cigna TTK filed an application with the Insurance Regulatory and Development Authority of India (IRDAI) to increase Cigna's stake in the firm from 26 per cent to 49 per cent.


    Cigna TTK Health Insurance is a joint venture between US-based Cigna Corporation and TTK Group.


    ET reports that following the transaction, TTK will own 51% stake. TTK is in the process of selling its stake partially or completely in the business. The company has a share capital of Rs 250 crore, which will expand to Rs 350 crore after this round.


    Sandeep Patel, managing director, Cigna TTK Health Insurance said, “Cigna TTK will continue to strengthen its market position in India by further growing our distribution network through expansion and new alliances, focusing on product and service innovation and enhancing our digital and technological capabilities while keeping the customer at the centre of everything we do.”


    “We look forward to continuing our journey to improve the health, well-being, and sense of security of the people we serve.” The standalone health insurance company has more than 300,000 customers in India, with a network of 15 branches and presence in 6,000 locations through its point-of-sale network.


    Sandeep Patel told TOI that the US partner did not view the new legislation, which mandated that insurance companies should be Indian-owned and Indian-managed, as a deal-breaker. Cigna had taken a decision to deepen its ownership as India was a strategic market for Cigna's international operations.


    Patel said that the fresh investment would be used to invest in digital technology, reduce costs and improve customer experience. "At present 50% of our premium comes in without any paperwork. Our objective is to take this to 80%," said Patel.

    cignaCigna TTKfresh investmenthealth insuranceincreaseInsurance Regulatory and Development Authority of IndiaIRDAIjoint ventureSandeep Patelstake
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok